查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912615

临床一次性采血管市场：全球预测（2026-2032 年），依产品类型、材料、帽型、产品形式和最终用户划分

Clinical Disposable Blood Collection Tube Market by Product Type, Material, Closure Type, Product Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，临床一次性采血管市场规模将达到 30.2 亿美元，到 2026 年将成长至 32 亿美元，到 2032 年将达到 53.2 亿美元，复合年增长率为 8.42%。

主要市场统计数据
基准年 2025 30.2亿美元
预计年份：2026年 32亿美元
预测年份：2032年 53.2亿美元
复合年增长率 (%) 8.42%

临床一次性采血管的策略概述：重点在于分析前完整性、操作相容性以及不断变化的产品和供应链趋势

临床一次性采血管是现代检查室工作流程中不可或缺的一部分，也是决定后续诊断准确性和病人安全的第一步分析前处理。由于这些一次性耗材直接接触患者检体和自动化实验室系统，其设计、材料和添加剂都会影响检体稳定性、与分析平台的兼容性以及储存和运输。随着检查室处理能力的提升和自动化物流处理检体的日益完善，对采血管的要求也从简单的密封容器发展到能够确保多种检测方法下分析物完整性的工程化系统。

自动化、日益严格的监管审查、永续性要求以及供应链重组正在从整体上重新定义产品开发和筹资策略。

临床一次性采血管市场正经历一系列变革，这些变革由技术、监管和环境因素驱动，重塑产品设计和筹资策略。自动化和实验室设备的进步推动了采血管尺寸、管盖可用性和添加剂化学成分的标准化，这要求其可靠地与高速离心机、条码工作流程和机器人检体处理系统整合。同时，就地检验和分散式采样模式的兴起，也推动了对非传统规格采血管的需求，这些采血管强调便携性、易用性和与检体检测的兼容性。

评估关税引发的成本压力和供应链调整对临床一次性采血管采购的累积营运和策略影响

2025年的政策环境引入了一系列关税措施和贸易考量，对临床一次性采血管供应链中依赖进口的环节施加了累积压力。某些聚合物原料、玻璃零件和配件的关税上调推高了到岸成本，迫使采购团队重新评估供应商合约和库存策略。同时，运费波动和海关拥堵增加了即时补货模式的风险，促使医疗机构和经销商考虑建立缓衝库存、在地采购和签订长期供应协议，以降低关税引发的价格波动风险。

将产品类型、材料成分、最终用户需求、瓶盖技术和生产方式与临床和采购优先事项联繫起来的细分市场分析

细分市场层面的细微差别揭示了产品创新、采购重点和临床应用如何交织，共同塑造商业性优先事项。依产品类型划分，市场分为非真空管和真空管。这种细分突显了应用情境的差异：真空管在高通量临床检查室中仍然至关重要，因为这些实验室需要标准化的采血量和可预测的真空性能；而非真空管则越来越多地应用于毛细血管采样、小容量检测和照护现场等注重便捷性和便携性的环境中。按材料划分，市场分为玻璃管和塑胶管。从玻璃管转向工程塑胶管反映了诸如破损风险、重量和运输效率以及与现代离心机和机器人系统的兼容性等因素。然而，对于某些特定分析物以及优先考虑特定检测长期稳定性的检查室而言，玻璃管仍具有优势。

区域趋势影响采购、製造地和监管合规：美洲、欧洲、中东和非洲以及亚太市场

区域趋势在全球供应链的筹资策略、监管合规和创新路径中发挥关键作用。在美洲，成熟的诊断基础设施和大规模的临床检查室能力推动了对标准化、自动化试管的需求。同时，政策和采购实践越来越倾向于支持本地製造，以增强供应链的韧性。这种环境鼓励对国内生产能力的投资，并采用优先考虑检验的供应商和长期合约的合作采购模式。而欧洲、中东和非洲的监管和采购环境则各不相同。西欧倾向于强调严格的品质标准、永续性要求以及与集中式检测网路的整合，而中东和非洲则面临基础设施差异，可能更注重价格和物流的稳健性，而非先进的自动化能力。

竞争格局的特点是：老字型大小企业、专业的创新者以及以品质保证、产能扩张和永续性倡议为驱动的策略伙伴关係关係。

临床一次性采血管市场的竞争动态由两类厂商构成：一类是拥有广泛产品系列的现有製造商，另一类是专注于特定应用和地理市场的专业供应商。市场领导往往强调其强大的品质系统、检验以及与主流分析平台的兼容性，而小规模的创新者则专注于特殊材料、新型管盖设计以及针对复杂分析物的特殊配方技术。策略性倡议包括：扩大产能以服务大型综合实验室客户；与设备製造商合作以确保系统级相容性；以及选择性垂直整合以控制关键的上游材料，例如聚合物树脂和隔膜组件。

为製造商和负责人提供切实可行的策略建议，以增强供应链韧性，加快采用检验的材料，并将永续性与商业目标结合。

行业领导者可以透过一系列切实可行的步骤来确保竞争力并维持业务永续营运，这些步骤将采购、产品开发和监管事务协调起来。首先，企业应透过多元化供应链并对关键零件的替代供应商进行资格认证，来降低贸易中断和关税波动带来的风险。同时，企业应制定安全库存政策，以平衡营运资金和服务水准保障。其次，投资于材料检验专案可以加快替代聚合物和封盖系统的引入，同时不会影响分析物的稳定性。实验室、品管和监管团队的检验可以加速商业化部署。

采用严谨的多方法研究方法，结合专家访谈、监管技术审查和检验，以检验产业调查结果。

本研究整合了多种研究方法，包括一手访谈、系统性二手资料研究和针对性观察分析，旨在全面整体情况临床一次性采血管生态系统。一级资讯来源包括与采购人员、实验室主任和技术专家的结构化访谈，以了解实际应用中的性能要求、检验方法和筹资策略。二手资料研究涵盖了监管文件、规范指南、关于检体稳定性和辅料化学的科学文献以及公开的公司披露信息，以检验相关声明并识别技术发展趋势。

策略要务综合分析表明，技术检验、供应链韧性和永续性优先事项将如何决定未来的竞争力。

临床一次性采血管领域处于临床需求、生产能力和政策趋势的交汇点，因此成为各机构寻求提升诊断可靠性和营运韧性的重点。材料和封盖技术的创新正在切实提升检体完整性和自动化相容性，而永续性和监管趋势正在重塑产品生命週期和采购要求。同时，关税因素和区域动态迫使企业采取灵活的筹资策略，并投资短期缓解措施以保障服务连续性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：临床一次性采血管市场（依产品类型划分）

  • 非真空采血管
  • 真空采血管

9. 依材料分類的临床一次性采血管市场

  • 玻璃管
  • 塑胶管

第十章：以帽型分類的临床一次性采血管市场

  • 塑胶盖
  • 橡胶帽

第十一章：临床一次性采血管市场（依产品类型划分）

  • 单体管
  • 两段式管

第十二章：依最终使用者分類的临床一次性采血管市场

  • 诊所
  • 诊断中心
  • 医院检查室

第十三章：按地区分類的临床一次性采血管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：依集团分類的临床一次性采血管市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：各国临床一次性采血管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国临床一次性采血管市场

第十七章：中国临床一次性采血管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • FL Medical SRL
  • Greiner Bio One International Gmbh
  • Haemonetics Corporation
  • Kabe Labortechnik GmbH
  • Labtech Srl
  • Medtronic plc
  • Micsafe Medical Group
  • Nanjing Vazyme Medical Technology Co., Ltd.
  • Nipro Medical Corporation
  • Sarstedt AG & Co. KG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AE420CB13A62

The Clinical Disposable Blood Collection Tube Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.20 billion in 2026, with a CAGR of 8.42%, reaching USD 5.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.20 billion
Forecast Year [2032] USD 5.32 billion
CAGR (%) 8.42%

A strategic overview of clinical disposable blood collection tubes emphasizing pre-analytical integrity, operational compatibility, and evolving product and supply chain dynamics

Clinical disposable blood collection tubes are foundational components of modern laboratory workflows, providing the first step in the pre-analytical phase that determines downstream diagnostic accuracy and patient safety. These single-use consumables interface directly with patient samples and laboratory automation, and their design, materials, and additives influence sample stability, compatibility with analytic platforms, and logistics of storage and transport. As laboratories scale throughput and embrace more automated sample handling, the demands placed on tubes have evolved from simple containment to engineered systems that preserve analyte integrity across diverse testing modalities.

Consequently, manufacturers and buyers are confronted with a complex matrix of technical requirements, regulatory scrutiny, and sustainability pressures. Transitioning from legacy glass formats to engineered plastics, integrating specialized additives and coatings, and ensuring compatibility with high-throughput centrifugation and robotic handlers are now routine imperatives. At the same time, supply chain resilience and quality assurance are central considerations for healthcare providers that rely on uninterrupted access to validated primary collection devices. This introduction frames a pragmatic view of how product innovation, operational constraints, and policy dynamics converge to shape strategic choices across the clinical disposable blood collection tube ecosystem.

How automation, regulatory scrutiny, sustainability demands, and supply chain reconfiguration are collectively redefining product development and procurement strategies

The landscape for clinical disposable blood collection tubes is experiencing a set of transformative shifts driven by technological, regulatory, and environmental vectors that are reshaping product design and procurement strategies. Advances in automation and laboratory instrumentation have increased the need for tubes that reliably interface with high-speed centrifuges, barcoded workflows, and robotic sample handlers, prompting greater standardization around tube dimensions, closure reliability, and additive chemistry. At the same time, the proliferation of point-of-care testing and decentralized sampling models has spurred demand for non-traditional formats that prioritize portability, ease of use, and compatibility with micro-volume assays.

Regulatory attention and sustainability priorities are also altering product roadmaps. Regulators have intensified focus on traceability, material biocompatibility, and labeling accuracy, while hospital systems and diagnostic chains are increasingly evaluating the environmental footprint of single-use plastics and exploring recycling or alternative material strategies. As a result, manufacturers are balancing innovation in polymer science and closure technologies with lifecycle assessments and supplier transparency initiatives. Moreover, geopolitical changes and procurement policy shifts are redirecting sourcing strategies toward regionalized supply bases, collaborative vendor contracts, and dual-sourcing arrangements that collectively influence how product developers and purchasers plan for continuity and cost control.

Assessing the cumulative operational and strategic impacts from tariff-driven cost pressures and supply chain adjustments across clinical disposable blood collection tube sourcing

The policy landscape entering 2025 introduced a set of tariff measures and trade considerations that have exerted cumulative pressure on import-dependent segments of the clinical disposable blood collection tube supply chain. Increased duties on certain polymer inputs, glassware components, and accessory items have amplified landed costs and created a need for procurement teams to re-evaluate supplier contracts and inventory strategies. In tandem, freight volatility and customs bottlenecks have made just-in-time replenishment models riskier, encouraging healthcare providers and distributors to consider buffer stock, local sourcing, and longer-term supply agreements to mitigate exposure to tariff-driven price swings.

Industry responses have included investment in local manufacturing capabilities, renegotiation of commercial terms with overseas suppliers to share tariff burdens, and selective product reformulation to substitute taxed inputs where feasible. These adaptations are unfolded against a backdrop of contractual complexity; hospitals and diagnostic centers are sensitive to any cost pass-through that could affect service pricing or reimbursement alignment. Importantly, the cumulative effect of tariffs has not only been economic but strategic: organizations are revisiting supplier diversification, expanding qualification processes for alternative materials and closures, and accelerating supplier audits to secure regulatory-compliant, tariff-resilient supply chains. As a result, stakeholders across the ecosystem must account for tariff risk when planning capital investments, procurement cycles, and product development timelines.

Segment-level analysis linking product type, material composition, end-user requirements, closure technologies, and manufacturing mode to clinical and procurement priorities

Segment-level nuances reveal where product innovation, procurement emphasis, and clinical application intersect to shape commercial priorities. Based on Product Type, market is studied across Non Vacuum Tube and Vacuum Tube; this split underscores a divergence in use cases where vacuum tubes remain essential for high-throughput clinical laboratories requiring standardized draw volumes and predictable vacuum integrity, while non-vacuum formats are increasingly used for capillary sampling, small-volume assays, and point-of-care settings that value simplicity and portability. Based on Material, market is studied across Glass Tube and Plastic Tube; here the transition from glass to engineered plastics reflects considerations of breakage risk, weight and transport efficiencies, and compatibility with modern centrifugation and robotic systems, yet glass retains advantages for certain analytes and for laboratories emphasizing long-term stability in specific assays.

Based on End User, market is studied across Clinics, Diagnostic Centers, and Hospital Laboratories; end-user differentiation drives purchasing criteria, with clinics often prioritizing ease of use and cost per draw, diagnostic centers emphasizing throughput and standardized systems integration, and hospital laboratories demanding broad-spectrum compatibility and chain-of-custody features. Based on Closure Type, market is studied across Plastic Closure and Rubber Closure; closure choices affect sealing performance, needle-pierce reliability, and additive containment, thereby influencing clinician safety and sample integrity. Finally, based on Product Mode, market is studied across Monobloc Tube and Two Piece Tube; manufacturing mode impacts cost structure, dimensional tolerances, and automation-readiness, with monobloc assemblies offering simplified production and two-piece constructions enabling modularity and customization. Taken together, these segmentation dimensions illustrate where R&D, procurement, and quality assurance efforts must be targeted to align product attributes with end-user workflows and regulatory expectations.

Regional dynamics shaping procurement, manufacturing footprint, and regulatory compliance across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics play a critical role in shaping sourcing strategies, regulatory compliance, and innovation pathways across the global supply base. In the Americas, a mature diagnostics infrastructure and significant clinical laboratory capacity create high demand for standardized, automation-compatible tubes while policy and procurement practices are increasingly supportive of local manufacturing to enhance supply resilience. This environment has encouraged investment in domestic production capacity and collaborative procurement models that prioritize validated suppliers and long-term contracts. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory and procurement landscape: Western Europe often emphasizes stringent quality standards, sustainability mandates, and integration with centralized laboratory networks, whereas regions in the Middle East and Africa face infrastructure variability and may prioritize affordability and logistical robustness over advanced automation compatibility.

Asia-Pacific serves as both a fast-growing demand market and a major manufacturing hub for primary collection devices. Rapid expansion of diagnostic networks, rising healthcare access, and cost-led procurement have stimulated local suppliers to scale production and offer price-competitive alternatives, while export-oriented manufacturers in the region continue to influence global supply dynamics. Across all regions, stakeholders must navigate a mix of tariff regimes, regulatory harmonization efforts, and environmental policy initiatives that affect material choices, labeling requirements, and product lifecycle considerations. Consequently, regional strategies should be calibrated to account for differences in healthcare infrastructure, regulatory stringency, and supplier ecosystem maturity.

Competitive landscape characterized by legacy leaders, specialized innovators, and strategic partnerships driving quality assurance, capacity expansion, and sustainability initiatives

Competitive dynamics in the clinical disposable blood collection tube space are defined by a mix of legacy manufacturers with broad product portfolios and specialized suppliers focused on niche applications or regional markets. Market leaders tend to emphasize robust quality systems, traceability features, and validated compatibility with major analytical platforms, while smaller innovators bring specialized materials, novel closure designs, and targeted formulations for challenging analytes. Strategic activity includes capacity expansion to serve larger integrated laboratory customers, partnerships with instrument manufacturers to ensure system-level compatibility, and selective vertical integration to control critical upstream inputs such as polymer resins and septum components.

Another notable trend is the prioritization of sustainability and circularity programs, with several firms investing in material innovation and end-of-life management pilots, as well as pursuing certifications that resonate with procurement teams seeking to reduce lifecycle environmental impacts. Mergers and acquisitions, joint ventures, and contract manufacturing arrangements are also reshaping competitive footprints, enabling companies to secure complementary capabilities and expand geographic reach. For procurement professionals, the supplier landscape requires a balanced evaluation of technical performance, production resilience, commercial flexibility, and the ability to support regulatory documentation and validation activities across diverse clinical settings.

Practical strategic recommendations for manufacturers and buyers to strengthen supply resilience, accelerate validated material adoption, and align sustainability with commercial goals

Industry leaders can safeguard competitiveness and operational continuity with a set of practical actions that align procurement, product development, and regulatory engagement. First, firms should diversify supply bases and qualify alternative suppliers for critical components to reduce exposure to trade disruptions and tariff volatility, while concurrently establishing safety-stock policies that balance working capital with service-level commitments. Second, investing in material validation programs will enable faster adoption of alternative polymers or closure systems without compromising analyte stability; cross-functional validation involving laboratories, quality, and regulatory teams will accelerate commercial deployment.

Third, proactive regulatory engagement is essential: early dialogue with regulators and robust documentation of biocompatibility, traceability, and labeling will reduce time-to-market risks and support procurement approvals. Fourth, embed sustainability into product roadmaps by assessing lifecycle impacts, piloting recyclable or lower-impact materials, and communicating verified environmental claims to hospital procurement groups. Fifth, pursue commercial arrangements that reflect shared risk, such as longer-term supply agreements, volume-based discounts, and collaborative forecasting that improve visibility across the supply chain. Finally, prioritize digital enablement-implement barcoding and sample-tracking enhancements that reduce pre-analytical error rates and create differentiated value propositions for laboratory customers. Collectively, these recommendations will help manufacturers and buyers navigate cost pressures, regulatory expectations, and shifting clinical workflows.

A rigorous multi-method research approach integrating primary expert interviews, secondary regulatory and technical review, and triangulation to validate industry insights

This research synthesizes insights from a multi-method approach combining primary interviews, systematic secondary review, and targeted observational analysis to build a comprehensive picture of the clinical disposable blood collection tube ecosystem. Primary inputs included structured conversations with procurement leaders, laboratory directors, and technical experts who provided context on real-world performance requirements, validation practices, and sourcing strategies. Secondary review encompassed regulatory documents, standards guidance, scientific literature on sample stability and additive chemistry, and publicly available company disclosures to validate claims and identify technological trends.

To ensure robustness, findings were triangulated across multiple data streams and subjected to expert validation sessions that examined assumptions and interpretation. Supply chain mappings and manufacturing capability assessments were conducted through structured supplier profiling and capacity evaluation. The methodology acknowledges constraints: access to proprietary procurement contracts and specific supplier cost structures is limited, and regional heterogeneity can create variability in applicability. To mitigate these factors, the analysis emphasizes qualitative interpretation, scenario-based considerations, and sensitivity around regulatory and tariff-driven contingencies. Regular updates and client-specific extensions are recommended to maintain alignment with evolving policy and market conditions.

Synthesis of strategic imperatives demonstrating how technical validation, supply resilience, and sustainability priorities will determine future competitiveness

The clinical disposable blood collection tube domain sits at the intersection of clinical need, manufacturing capability, and policy forces, making it a focal point for organizations aiming to improve diagnostic reliability and operational resilience. Innovations in materials and closure technologies are delivering tangible benefits in sample integrity and automation compatibility, while sustainability and regulatory trends are reshaping product lifecycles and procurement expectations. Simultaneously, tariff considerations and regional dynamics require companies to adopt flexible sourcing strategies and to invest in near-term mitigation measures that protect service continuity.

Looking ahead, stakeholders who align technical validation with strategic sourcing, who engage regulators proactively, and who pursue sustainability without sacrificing performance will be best positioned to capture value and reduce operational risk. The synthesis of segmentation and regional insights highlights targeted opportunities for product differentiation-particularly in materials selection, closure engineering, and automation-friendly formats-while the competitive review underscores the importance of partnerships and validated supply chains. In short, a balanced focus on technical excellence, supply chain resilience, and adaptive commercial models will be critical for navigating near-term headwinds and for realizing long-term gains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Clinical Disposable Blood Collection Tube Market, by Product Type

  • 8.1. Non Vacuum Tube
  • 8.2. Vacuum Tube

9. Clinical Disposable Blood Collection Tube Market, by Material

  • 9.1. Glass Tube
  • 9.2. Plastic Tube

10. Clinical Disposable Blood Collection Tube Market, by Closure Type

  • 10.1. Plastic Closure
  • 10.2. Rubber Closure

11. Clinical Disposable Blood Collection Tube Market, by Product Mode

  • 11.1. Monobloc Tube
  • 11.2. Two Piece Tube

12. Clinical Disposable Blood Collection Tube Market, by End User

  • 12.1. Clinics
  • 12.2. Diagnostic Centers
  • 12.3. Hospital Laboratories

13. Clinical Disposable Blood Collection Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Clinical Disposable Blood Collection Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Clinical Disposable Blood Collection Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Clinical Disposable Blood Collection Tube Market

17. China Clinical Disposable Blood Collection Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Becton, Dickinson and Company
  • 18.6. Bio-Rad Laboratories, Inc.
  • 18.7. FL Medical S.R.L.
  • 18.8. Greiner Bio One International Gmbh
  • 18.9. Haemonetics Corporation
  • 18.10. Kabe Labortechnik GmbH
  • 18.11. Labtech S.r.l.
  • 18.12. Medtronic plc
  • 18.13. Micsafe Medical Group
  • 18.14. Nanjing Vazyme Medical Technology Co., Ltd.
  • 18.15. Nipro Medical Corporation
  • 18.16. Sarstedt AG & Co. KG
  • 18.17. Terumo Corporation
  • 18.18. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY NON VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY RUBBER CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MONOBLOC TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MONOBLOC TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MONOBLOC TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY TWO PIECE TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY TWO PIECE TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY TWO PIECE TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 101. GCC CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 119. G7 CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 125. NATO CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 132. UNITED STATES CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT MODE, 2018-2032 (USD MILLION)
  • TABLE 138. CHINA CLINICAL DISPOSABLE BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)